These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9743220)

  • 1. Variation in gut-homing CD27-negative lymphocytes in inflammatory colon disease.
    Meenan J; Spaans J; Grool TA; Lammers K; Pals S; Tytgat GN; van Deventer SJ
    Scand J Immunol; 1998 Sep; 48(3):318-23. PubMed ID: 9743220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered expression of alpha 4 beta 7, a gut homing integrin, by circulating and mucosal T cells in colonic mucosal inflammation.
    Meenan J; Spaans J; Grool TA; Pals ST; Tytgat GN; van Deventer SJ
    Gut; 1997 Feb; 40(2):241-6. PubMed ID: 9071939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients with inflammatory bowel disease (IBD) reveal increased induction capacity of intracellular interferon-gamma (IFN-gamma) in peripheral CD8+ lymphocytes co-cultured with intestinal epithelial cells.
    Bisping G; Lügering N; Lütke-Brintrup S; Pauels HG; Schürmann G; Domschke W; Kucharzik T
    Clin Exp Immunol; 2001 Jan; 123(1):15-22. PubMed ID: 11167992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of lymphocyte-endothelial receptor-ligand pairs, alpha4beta7/MAdCAM-1 and OX40/OX40 ligand in the colon and jejunum of patients with inflammatory bowel disease.
    Souza HS; Elia CC; Spencer J; MacDonald TT
    Gut; 1999 Dec; 45(6):856-63. PubMed ID: 10562584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of CD45RB functionally distinguishes intestinal T lymphocytes in inflammatory bowel disease.
    Ten Hove T; The Olle F; Berkhout M; Bruggeman JP; Vyth-Dreese FA; Slors JF; Van Deventer SJ; Te Velde AA
    J Leukoc Biol; 2004 Jun; 75(6):1010-5. PubMed ID: 15020649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profiles of Lamina Propria T Helper Cell Subsets Discriminate Between Ulcerative Colitis and Crohn's Disease.
    Li J; Ueno A; Fort Gasia M; Luider J; Wang T; Hirota C; Jijon HB; Deane M; Tom M; Chan R; Barkema HW; Beck PL; Kaplan GG; Panaccione R; Qian J; Iacucci M; Gui X; Ghosh S
    Inflamm Bowel Dis; 2016 Aug; 22(8):1779-92. PubMed ID: 27243594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered expression of interferon-gamma and interleukin-4 in inflammatory bowel disease.
    Camoglio L; Te Velde AA; Tigges AJ; Das PK; Van Deventer SJ
    Inflamm Bowel Dis; 1998 Nov; 4(4):285-90. PubMed ID: 9836081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The proportion of Th1 cells, which prevail in gut mucosa, is decreased in inflammatory bowel syndrome.
    Van Damme N; De Keyser F; Demetter P; Baeten D; Mielants H; Verbruggen G; Cuvelier C; Veys EM; De Vos M
    Clin Exp Immunol; 2001 Sep; 125(3):383-90. PubMed ID: 11531945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crossover Subsets of CD4
    Li J; Ueno A; Iacucci M; Fort Gasia M; Jijon HB; Panaccione R; Kaplan GG; Beck PL; Luider J; Barkema HW; Qian J; Gui X; Ghosh S
    Dig Dis Sci; 2017 Sep; 62(9):2357-2368. PubMed ID: 28573508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced CD27
    Pararasa C; Zhang N; Tull TJ; Chong MHA; Siu JHY; Guesdon W; Chavele KM; Sanderson JD; Langmead L; Kok K; Spencer J; Vossenkamper A
    Front Immunol; 2019; 10():361. PubMed ID: 30891036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lamina Propria CD4+LAP+ Regulatory T Cells Are Increased in Active Ulcerative Colitis but Show Increased IL-17 Expression and Reduced Suppressor Activity.
    D'Ambrosio A; Cossu A; Amendola A; Zandri A; Butera A; Sanchez M; Biffoni M; Pronio A; Montesani C; Kohn A; Pica R; Boirivant M
    J Crohns Colitis; 2016 Mar; 10(3):346-53. PubMed ID: 26589955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.
    Fuss IJ; Neurath M; Boirivant M; Klein JS; de la Motte C; Strong SA; Fiocchi C; Strober W
    J Immunol; 1996 Aug; 157(3):1261-70. PubMed ID: 8757634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Over-expression of interleukin 10 in mucosal T cells of patients with active ulcerative colitis.
    Melgar S; Yeung MM; Bas A; Forsberg G; Suhr O; Oberg A; Hammarstrom S; Danielsson A; Hammarstrom ML
    Clin Exp Immunol; 2003 Oct; 134(1):127-37. PubMed ID: 12974765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-2 production in pediatric inflammatory bowel disease: evidence for dissimilar mononuclear cell function in Crohn's disease and ulcerative colitis.
    Gurbindo C; Sabbah S; Menezes J; Justinich C; Marchand R; Seidman EG
    J Pediatr Gastroenterol Nutr; 1993 Oct; 17(3):247-54. PubMed ID: 8271122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TL1A as a Potential Local Inducer of IL17A Expression in Colon Mucosa of Inflammatory Bowel Disease Patients.
    Ślebioda TJ; Bojarska-Junak A; Stanisławowski M; Cyman M; Wierzbicki PM; Roliński J; Celiński K; Kmieć Z
    Scand J Immunol; 2015 Oct; 82(4):352-60. PubMed ID: 26072972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid migration of thymic emigrants to the colonic mucosa in ulcerative colitis patients.
    Elgbratt K; Kurlberg G; Hahn-Zohric M; Hörnquist EH
    Clin Exp Immunol; 2010 Nov; 162(2):325-36. PubMed ID: 20840654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct patterns of naive, activated and memory T and B cells in blood of patients with ulcerative colitis or Crohn's disease.
    Rabe H; Malmquist M; Barkman C; Östman S; Gjertsson I; Saalman R; Wold AE
    Clin Exp Immunol; 2019 Jul; 197(1):111-129. PubMed ID: 30883691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral cytokine profile in Chilean patients with Crohn's disease and ulcerative colitis.
    Beltrán CJ; Candia E; Erranz B; Figueroa C; Gonzalez MJ; Quera R; Hermoso MA
    Eur Cytokine Netw; 2009 Mar; 20(1):33-8. PubMed ID: 19318319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of a role for interleukin-13 in inflammatory bowel disease.
    Biancheri P; Di Sabatino A; Ammoscato F; Facciotti F; Caprioli F; Curciarello R; Hoque SS; Ghanbari A; Joe-Njoku I; Giuffrida P; Rovedatti L; Geginat J; Corazza GR; MacDonald TT
    Eur J Immunol; 2014 Feb; 44(2):370-85. PubMed ID: 24338958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of interleukin-12 and -17 in active inflammatory bowel disease.
    Nielsen OH; Kirman I; Rüdiger N; Hendel J; Vainer B
    Scand J Gastroenterol; 2003 Feb; 38(2):180-5. PubMed ID: 12678335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.